New Delhi: Days after the news broke that DRDO has come up with a drug that has anti COVID properties, it has now also been reported that Pune-based Mylab Discovery Solutions is going to launch India’s first self-use rapid antigen test (RAT) kit for Covid-19 for Rs 250 per pack.
The product has been cleared by Indian Council of Medical Research (ICMR).
The test results that comeout of it will have to be uploaded by home users themselves through an app that is available on Google play store and Apple store.
Notably the data in the app of the mobile phone will be centrally captured in a secure server connected with the ICMR COVID-19 testing portal. All data will be eventually stored, ICMR said in an advisory.
Named CoviSelf, the self-use test can be used by symptomatic individuals and immediate contacts of confirmed cases as per ICMR guidelines. The test kits will be available for purchase without a prescription from local pharmacies and online channel partners. This will make things simpler for already burdened testing labs and reduce delays in testing, which is more than 72 hours in some parts of the country.
As per an ICMR advisory all individuals who test positive may be considered as true positives and no repeat testing is required. However, all RAT negative symptomatic individuals will be treated as suspect Covid-19 cases. They will have to follow the ICMR/ Health ministry home isolation protocol. Each kit will be provided with all testing materials, instructions to use (IFU) leaflet and a biohazard bag to safely dispose after testing.
The company will start shipping out tests within a few days.
ICMR has approved the self-test rapid antigen Covid-19 testing kit 'Coviself' developed by Mylab Solutions. Using the kit people can collect their own nasal swab and check results within minutes. This will immensely help in early and quick detection.https://t.co/kPfdmG125K
— Shubhankar Saha (@Shubhankarasaha) May 20, 2021